Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jul 29:15:1433-1445.
doi: 10.2147/RMHP.S368057. eCollection 2022.

Prevalence and Determinants of COVID-19 Vaccine Hesitancy Among the Ethiopian Population: A Systematic Review

Delelegn Emwodew Yehualashet  1 , Binyam Tariku Seboka  1 , Getanew Aschalew Tesfa  1 , Tizalegn Tesfaye Mamo  1 , Mulugeta Namaro Yawo  1 , Samuel Hailegebreal  2
Affiliations
Review

Prevalence and Determinants of COVID-19 Vaccine Hesitancy Among the Ethiopian Population: A Systematic Review

Delelegn Emwodew Yehualashet et al. Risk Manag Healthc Policy. .

Abstract

Introduction: Although vaccination is the most effective way to end the COVID-19 pandemic, there are growing concerns that vaccine hesitancy may undermine its effectiveness. In Ethiopia, vaccine hesitancy forms a major challenge to the uptake of COVID-19 vaccines. This systematic review examined the prevalence and determinants of the COVID-19 vaccine hesitancy among the Ethiopian population.

Methods: A systematic search of articles was conducted in PubMed, EBSCO, Google Scholar, and Semantic Scholar. Studies that evaluated the prevalence and determinants of COVID-19 vaccine hesitancy in Ethiopia were included. The identified determinants of COVID-19 vaccine hesitancy were analyzed based on the frequency of occurrence in the included studies.

Results: The overall COVID-19 vaccine hesitancy level in the Ethiopian population ranged from 14.1% to 68.7%. The high COVID-19 vaccine hesitancy rate observed in this study was due to contextual factors, individual factors, and vaccine-specific factors. Young age, female sex, living in rural areas, lack of adequate information, and lower education are the most common contextual determinants of the COVID-19 vaccine hesitancy. Lack of awareness about the COVID-19 vaccine, low risk of COVID-19, poor adherence to COVID-19 prevention strategies, and negative attitude towards the COVID-19 vaccine are the most frequently reported personal factors. Common vaccine-specific determinants of COVID-19 vaccine hesitation are the side effects of the vaccine and doubts about its effectiveness of the vaccine.

Conclusion: Our review showed that COVID-19 vaccine hesitancy remains highly prevalent and varied across regions of Ethiopia, with a wide variety of factors associated with it. Potential interventions on the benefits of vaccination and the adverse effects of vaccine rejection are crucial to enhance COVID-19 vaccine uptake among the Ethiopian population.

Keywords: COVID-19; Ethiopia; acceptance; hesitancy; systematic review; vaccine.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest in this work.

Figures

Figure 1
Figure 1
PRISMA flow chart of study selection process for systematic review of the prevalence and determinants of COVID-19 vaccine hesitancy among the Ethiopian population.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Song F, Shi N, Shan F, et al. Emerging 2019 Novel Coronavirus (2019-nCoV) Pneumonia. Radiology. 2020;295(1):210–217. doi:10.1148/radiol.2020200274 - DOI - PMC - PubMed
    1. WHO director-general’s opening remarks at the media briefing on COVID-19-11 March 2020. Available from: https://www.who.int/directorgeneral/speeches/detail/who-director-general.... Accessed July 25, 2022.
    1. Noh J, Danuser G. Estimation of the fraction of COVID-19 infected people in U.S. states and countries worldwide. PLoS One. 2021;16(2):e0246772. doi:10.1371/journal.pone.0246772 - DOI - PMC - PubMed
    1. World Health Organization. Coronavirus disease (COVID-19): vaccines safety; 2021. Available from: https://www.who.int/news-room/q-a-detail/coronavirus-disease-(covid-19)-.... Accessed July 25, 2022.
    1. Centers for Disease Control and Prevention. Vaccine safety and monitoring; 2021. Available from: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety.html. Accessed July 25, 2022.